A detailed history of Wells Fargo & Company transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 177,835 shares of AMRX stock, worth $1.49 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
177,835
Previous 59,345 199.66%
Holding current value
$1.49 Million
Previous $376,000 293.35%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$6.42 - $8.83 $760,705 - $1.05 Million
118,490 Added 199.66%
177,835 $1.48 Million
Q2 2024

Aug 13, 2024

BUY
$5.36 - $7.11 $58,247 - $77,264
10,867 Added 22.42%
59,345 $376,000
Q1 2024

May 10, 2024

BUY
$5.24 - $6.34 $54,296 - $65,695
10,362 Added 27.19%
48,478 $293,000
Q4 2023

Feb 09, 2024

BUY
$3.36 - $6.21 $23,089 - $42,675
6,872 Added 21.99%
38,116 $231,000
Q3 2023

Nov 13, 2023

SELL
$2.76 - $4.59 $69,723 - $115,952
-25,262 Reduced 44.71%
31,244 $131,000
Q2 2023

Aug 15, 2023

BUY
$1.33 - $3.1 $45,773 - $106,689
34,416 Added 155.8%
56,506 $175,000
Q1 2023

May 12, 2023

BUY
$1.27 - $2.7 $26,516 - $56,373
20,879 Added 1724.11%
22,090 $30,000
Q4 2022

Feb 13, 2023

SELL
$1.96 - $2.61 $24,795 - $33,019
-12,651 Reduced 91.26%
1,211 $2,000
Q3 2022

Nov 14, 2022

SELL
$2.02 - $3.62 $2,266 - $4,061
-1,122 Reduced 7.49%
13,862 $28,000
Q2 2022

Aug 12, 2022

SELL
$3.01 - $4.46 $667,672 - $989,308
-221,818 Reduced 93.67%
14,984 $48,000
Q1 2022

May 16, 2022

SELL
$3.9 - $4.89 $589,293 - $738,883
-151,101 Reduced 38.95%
236,802 $988,000
Q4 2021

Feb 14, 2022

SELL
$3.95 - $5.85 $1.45 Million - $2.15 Million
-366,788 Reduced 48.6%
387,903 $1.86 Million
Q3 2021

Nov 15, 2021

SELL
$4.31 - $5.64 $516,825 - $676,309
-119,913 Reduced 13.71%
754,691 $4.03 Million
Q2 2021

Aug 16, 2021

BUY
$5.12 - $6.82 $209,008 - $278,406
40,822 Added 4.9%
874,604 $4.48 Million
Q1 2021

May 13, 2021

BUY
$4.74 - $7.38 $2.36 Million - $3.67 Million
497,351 Added 147.83%
833,782 $5.61 Million
Q4 2020

Feb 09, 2021

SELL
$3.95 - $5.42 $140,983 - $193,450
-35,692 Reduced 9.59%
336,431 $1.54 Million
Q3 2020

Nov 05, 2020

BUY
$3.54 - $5.27 $223,458 - $332,663
63,124 Added 20.43%
372,123 $1.45 Million
Q2 2020

Aug 13, 2020

BUY
$2.87 - $5.46 $271,711 - $516,914
94,673 Added 44.17%
308,999 $1.47 Million
Q1 2020

May 14, 2020

BUY
$2.46 - $5.35 $527,241 - $1.15 Million
214,326 New
214,326 $746,000

Others Institutions Holding AMRX

About Amneal Pharmaceuticals, Inc.


  • Ticker AMRX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 151,408,992
  • Market Cap $1.27B
  • Description
  • Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...
More about AMRX
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.